SCHEMBL7007018

SCHEMBL7007018

N#CCC1(NC(=O)C(CC2CCCCC2)N=C2NC(=O)c3cc(F)c(F)cc32)CCNCC1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CTSL P07711 3/20 0.33
CTSS P25774 3/20 0.33
CTSD P07339 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7005970 0.92 CTSL (0.36) CTSLCTSSCTSD
SCHEMBL6352282 0.79 CTSS (0.47) CTSLCTSS
SCHEMBL6352278 0.79 CTSS (0.47) CTSLCTSS
SCHEMBL7011171 0.74 CTSS (0.35) CTSLCTSS
SCHEMBL7007715 0.72 CTSS (0.39) CTSLCTSS
SCHEMBL6345935 0.72 CTSS (0.45) CTSLCTSS
SCHEMBL7010769 0.69 CTSL (0.32) CTSLCTSS
SCHEMBL5363187 0.68 CTSS (0.39) CTSLCTSS
SCHEMBL7007584 0.68 CTSL (0.51) CTSLCTSS
SCHEMBL7004000 0.66 CTSS (0.50) CTSLCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1322613-A1 SPIROHETEROCYCLIC NITRILES USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2003-07-02 EP claimed
WO-2002020485-A1 SPIROHETEROCYCLIC NITRILES USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2002-03-14 WO claimed
EP-1322613-A1 SPIROHETEROCYCLIC NITRILES USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2003-07-02 EP disclosed
WO-2002020485-A1 SPIROHETEROCYCLIC NITRILES USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2002-03-14 WO disclosed